Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Ambidirectional Clinical and Biological Cohort Study of Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases

NCT07727083 is registered in ClinicalTrials.gov with Rong Tao as lead sponsor.

NCT NCT07727083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07727083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Ambidirectional Clinical and Biological Cohort Study of Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases
Lead sponsor
Rong Tao
Phase
Observational
Overall status
Recruiting
Start date
August 11, 2026
Completion date
December 31, 2035
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aggressive nk-cell leukemia, epstein-barr virus-positive nodal t/nk-cell lymphoma, epstein-barr virus-positive t/nk-cell lymphoproliferative disease, extranodal nk/t-cell lymphoma, systemic chronic active epstein-barr virus disease